TORONTO, ONTARIO -- (Marketwired) -- 08/08/13 -- NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE: NXG) is pleased to report financial results for its second quarter, ended June 30, 2013.Revenue from transaction fees for the quarter ended June 30, 2013 was $1,275,76 ...
↧